Open Access

SGLT2 Inhibitor HFpEF Data: From Context to Clinical Pearls

Event: ESC Congress 2021 - The Digital Experience
Topic: Chronic Heart Failure
Session type: Satellite Symposium
Organised by Medscape – Supported by an unrestricted educational grant from Boehringer Ingelheim and Eli Lilly and Company Alliance
Date: 28 August 2021
Time: 16:50 - 17:20

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

6 presentations in this session

Introduction.

Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

My Heart, My Life.

Speaker: Professor L. Lund (Stockholm, SE)
Thumbnail

EMPEROR-Preserved in Context.

Speaker: Professor C. Lam (Singapore, SG)
Speaker: Professor J. Butler (Jackson, US)
Thumbnail

HFpEF Treatment: Clinical Pearls.

Speaker: Professor C. Lam (Singapore, SG)
Speaker: Professor J. Butler (Jackson, US)
Speaker: Professor L. Lund (Stockholm, SE)
Thumbnail

Summary and Conclusions.

Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

Live Q&A.

Thumbnail

8 speakers from this session

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
99 presentations
14 followers

Professor Lars Lund

Karolinska Institute, Stockholm (Sweden)
47 presentations
2 followers

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
99 presentations
14 followers

Professor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
67 presentations
3 followers

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
99 presentations
14 followers

Professor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
67 presentations
3 followers

Professor Lars Lund

Karolinska Institute, Stockholm (Sweden)
47 presentations
2 followers

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
99 presentations
14 followers

Related content

Open Access

Trials Focus: GUIDE-HF / EMPEROR-Preserved

3 December 2021

Open Access

Current controversies in antithrombotic therapy

3 December 2021

Open Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk